{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/123137007"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "20110123535Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival - The invention provides methods of treating diseases, disorders or injuries involving oligodendrocyte death, demyelination and dysmyelination, including spinal cord injury, by the administration of an NgR1 antagonist.05-26-2011" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "faqs.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/106108555"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/123137007"] } } }
